Peter Whitehead, Founder, Director, Chairman of the Board, CEO
Peter Whitehead brings over 15 years of experience to the table in medicine, biochemistry, biophysics research, and biomedical product development in the field of cardiology. For several years, Peter worked one-on-one with international thought leaders in oral medicine and cardiology.

He is published in peer-reviewed cardiology journals; invented and patented fluorescence image- based cardiac transplant rejection monitor products; and has patents awarded and filed in endoscope development. Peter has taken three projects from concept to human use. Before the age of 30, Peter brought a medical device company from conception to a $50-million market cap